Soumit Roy
Stock Analyst at Jones Trading
(3.61)
# 840
Out of 5,139 analysts
44
Total ratings
38.24%
Success rate
13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WHWK Whitehawk Therapeutics | Initiates: Buy | $7 | $2.91 | +140.55% | 1 | Dec 22, 2025 | |
| CNTX Context Therapeutics | Initiates: Buy | $7 | $1.44 | +386.11% | 1 | Dec 22, 2025 | |
| EVAX Evaxion | Initiates: Buy | $10 | $4.55 | +119.78% | 1 | Oct 30, 2025 | |
| AVXL Anavex Life Sciences | Downgrades: Hold | n/a | $5.01 | - | 1 | Oct 24, 2025 | |
| CGON CG Oncology | Initiates: Buy | $50 | $54.73 | -8.64% | 1 | Sep 8, 2025 | |
| TARA Protara Therapeutics | Initiates: Buy | $21 | $5.01 | +319.16% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $20.86 | +91.75% | 1 | May 20, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $36 → $27 | $26.71 | +1.09% | 2 | May 16, 2025 | |
| ACRV Acrivon Therapeutics | Downgrades: Hold | n/a | $1.98 | - | 2 | May 16, 2025 | |
| ONCY Oncolytics Biotech | Downgrades: Hold | n/a | $1.01 | - | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 | $7.28 | +106.04% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $5.85 | +70.94% | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $34 | $31.22 | +8.90% | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $36 | $2.59 | +1,289.96% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $3.00 | +966.67% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $8.26 | +8.96% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $12.12 | +40.26% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.03 | +540.39% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $64 | $8.28 | +672.95% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.04 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.36 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $10.72 | +142.54% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $13.76 | +408.72% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $70.00 | -85.71% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.36 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $12.67 | +531.41% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.67 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $1.38 | +23,088.41% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $4.05 | +19,900.00% | 1 | Feb 24, 2021 |
Whitehawk Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $2.91
Upside: +140.55%
Context Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $1.44
Upside: +386.11%
Evaxion
Oct 30, 2025
Initiates: Buy
Price Target: $10
Current: $4.55
Upside: +119.78%
Anavex Life Sciences
Oct 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $5.01
Upside: -
CG Oncology
Sep 8, 2025
Initiates: Buy
Price Target: $50
Current: $54.73
Upside: -8.64%
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $5.01
Upside: +319.16%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $20.86
Upside: +91.75%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $26.71
Upside: +1.09%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.98
Upside: -
Oncolytics Biotech
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.01
Upside: -
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $7.28
Upside: +106.04%
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $5.85
Upside: +70.94%
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $31.22
Upside: +8.90%
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $2.59
Upside: +1,289.96%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $3.00
Upside: +966.67%
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $8.26
Upside: +8.96%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $12.12
Upside: +40.26%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $2.03
Upside: +540.39%
Sep 11, 2024
Maintains: Buy
Price Target: $96 → $64
Current: $8.28
Upside: +672.95%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.04
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $6.36
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $10.72
Upside: +142.54%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $13.76
Upside: +408.72%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $70.00
Upside: -85.71%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.36
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $12.67
Upside: +531.41%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.67
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $1.38
Upside: +23,088.41%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $4.05
Upside: +19,900.00%